Skip to content
In-house Gallium-68 generator · PSMA, DOTANOC & FAPI available daily · Complimentary pickup within 3 km
Neurad Diagnostic and Healthcare LLP Book a scan

PET CT Scan for Ovarian Cancer — Rising CA-125, Recurrence and What a Clear Scan Does Not Prove

Ovarian cancer behaves differently from most cancers, and that difference shapes exactly where a PET CT helps and where it does not.

Most cancers spread mainly through lymph nodes and the bloodstream. Ovarian cancer spreads largely by seeding — cells shed from the ovary settle across the peritoneum, the lining of the abdominal cavity, often as many very small deposits rather than a few discrete masses.

That single fact explains almost everything on this page: why PET is not the first test at diagnosis, why it becomes valuable when CA-125 rises after treatment, and why even a clear scan does not always mean what patients hope it means.

Why PET is usually not the first test

At initial presentation, the pathway is generally ultrasound, then a contrast CT of the chest, abdomen and pelvis, alongside CA-125 and clinical assessment. Sometimes an MRI, where the nature of a pelvic mass is uncertain.

PET CT is not routinely part of initial staging, for two reasons.

Small peritoneal deposits are below reliable detection. Where disease consists of numerous tiny implants across the peritoneal surface, no scan reliably maps them. Surgery — where the surgeon can see and feel the peritoneal surfaces directly — remains the definitive assessment. This is why staging in ovarian cancer is surgical rather than radiological.

Benign uptake in the pelvis is common. Physiological ovarian activity, endometriosis, inflammatory conditions and fibroids can all take up FDG. In a woman with an undiagnosed pelvic mass, a bright ovary does not settle the question.

So if your gynae-oncologist has ordered a CT and not a PET before surgery, that is standard practice.

Where PET genuinely earns its place

1. Rising CA-125 with unremarkable conventional imaging

This is the commonest and clearest use.

CA-125 is followed after treatment. A rise often precedes anything visible on CT — sometimes by months. When CA-125 climbs but the CT shows nothing definite, the clinical question becomes: where is it?

PET can identify metabolically active disease that has not yet produced a structural change large enough to see. Finding it — and knowing whether it is a single site or widespread — changes what happens next.

2. Assessing whether recurrent disease is operable

In selected patients with recurrence, further surgery can be worthwhile. That depends on whether the disease is confined enough to be removed.

A whole-body PET helps answer this by mapping the extent — checking whether there is disease outside the abdomen, or whether the abdominal disease is limited or diffuse. A patient with one or two resectable sites is in a different position from one with widespread peritoneal involvement.

3. Equivocal findings on CT

An indeterminate node, an uncertain liver lesion, a soft tissue area that may or may not be significant — situations where a functional assessment helps resolve the question.

4. Suspected recurrence with symptoms but no clear source

Where symptoms suggest disease has returned and conventional imaging has not localised it.

Understanding CA-125 properly

Since so much of the PET pathway in ovarian cancer is driven by this number, it is worth understanding what it does and does not mean.

It rises for benign reasons too

CA-125 is not specific to ovarian cancer. It can rise with endometriosis, fibroids, pelvic inflammatory disease, liver disease, heart failure, recent surgery, and even during menstruation and pregnancy.

This is precisely why a single raised value in a woman who has not been diagnosed with ovarian cancer is a reason to investigate, not a diagnosis — and why CA-125 is not used as a screening test in the general population.

The trend matters more than the number

After treatment, what your team watches is the direction and rate of change across several readings, not any single value. A value that has doubled over three measurements means something a single figure cannot.

Carry your CA-125 results over time, not just the latest one. The sequence gives the reporting physician context.

Some ovarian cancers do not produce it

Not all ovarian cancers raise CA-125. In those patients, follow-up relies more on clinical assessment and imaging.

The honest limitation: a clear PET does not exclude peritoneal disease

This is the most important thing on this page, and it is worth stating plainly rather than glossing over.

Because ovarian cancer often recurs as numerous very small peritoneal deposits, a PET showing no obvious disease does not guarantee that none is present. Deposits below a certain size are not reliably detected by PET, CT or MRI.

Two practical consequences:

If your CA-125 is rising and the PET is clear, your team may repeat imaging after an interval rather than concluding either way. That interval is uncomfortable, but it is often the correct decision — acting on an incomplete picture can be worse than waiting for a clearer one.

Where the exact extent of peritoneal disease matters — for instance in deciding whether cytoreductive surgery is feasible — laparoscopy may be used, because direct visualisation sees what imaging cannot.

Understanding this in advance prevents a great deal of confusion when a scan comes back normal but your doctor does not treat that as the end of the matter.

What else lights up and is not cancer

Physiological ovarian and endometrial activity

In premenopausal women, the ovaries and endometrium show cyclical uptake that varies through the menstrual cycle. Tell the centre the date of your last period. It is a clinical question, not an intrusive one, and it genuinely affects interpretation.

Endometriosis and fibroids

Both can take up FDG. Mention either if you have them.

The bladder

The tracer is excreted in urine and collects in the bladder, which sits directly in front of the pelvic organs being assessed. This is why you may be asked to drink water during the uptake period and to empty your bladder immediately before the acquisition — hydration dilutes the tracer and voiding clears it. These instructions directly affect whether the pelvis can be read properly.

Bowel activity

Normal bowel shows variable uptake throughout the abdomen, and in a disease where peritoneal surfaces are the concern, this frequently needs correlation with the CT appearance rather than being read alone.

After surgery

Surgical sites, adhesions and healing tissue take up the tracer. Mention the date of any surgery — and in ovarian cancer, most patients have had major abdominal surgery.

Ascites and drainage sites

If you have had ascitic fluid drained, or have a drain in place, mention it.

Infection

Any current infection or fever should be mentioned, as it produces intense uptake.

Preparation

Fasting

Usually around 6 hours. Plain water is allowed and, for pelvic imaging, actively important. No tea, coffee, juice, sweets or chewing gum.

Hydration and voiding

Follow the instructions given about drinking during the uptake period and emptying your bladder before the scan. In pelvic imaging these are not comfort measures.

Blood sugar

Checked before injection. Diabetic patients should mention it at booking so medication timing can be planned. Do not skip medication on your own initiative.

Avoid exertion

No strenuous activity for around 24 hours beforehand.

Lying flat with ascites

If you have abdominal distension from ascites, lying flat for the acquisition may be uncomfortable or make breathing harder. Tell the centre at booking rather than trying to endure it. Positioning can be adapted, and a patient who is struggling to breathe is a patient who moves.

Tell the centre these things when you book

  1. The date of your last menstrual period, if premenopausal
  2. Whether there is any possibility of pregnancy
  3. The date of any surgery, including debulking surgery
  4. Whether you have ascites, and whether it has been drained recently
  5. Whether you have a drain, stoma or port
  6. The dates of any chemotherapy
  7. Whether you have endometriosis or fibroids
  8. Any current infection or fever
  9. Whether you are diabetic, and what you take
  10. Whether you can lie flat comfortably

What to bring

  • The prescription, with the clinical indication written on it
  • CA-125 results over time, not just the most recent
  • All previous CT and MRI scans — films or CD
  • Previous PET scans, if any
  • Operative notes and histopathology — what was found and what was removed matters
  • Details of chemotherapy, including cycle dates
  • A list of current medications
  • Insurance or reimbursement papers, if you plan to file a claim
  • Photo identification

The operative notes deserve emphasis. In a disease where surgery is the definitive staging assessment, knowing what the surgeon saw and removed changes how imaging is interpreted afterwards.

Timing after chemotherapy

Chemotherapy causes inflammatory change, and it can also temporarily suppress uptake in tumour tissue. A scan performed too close to a cycle may therefore either over-represent or under-represent disease.

Response assessment scans are scheduled a defined interval after treatment for this reason. If your team has given you a date, that interval is deliberate.

Reading the report

An ovarian PET report describes the pelvis, then works systematically through the peritoneal surfaces, the omentum, the abdominal and pelvic nodes, the liver surface, the diaphragmatic surfaces, and then the chest — including the supraclavicular nodes.

The omentum and peritoneal surfaces are the areas that matter most in this disease, and a good report addresses them explicitly.

SUVmax measures tracer accumulation adjusted for dose and weight. It is not a cancer score — inflammation, infection, cyclical activity and post-surgical change all raise it. It is most meaningful compared against a previous scan.

A clear report should be read alongside your CA-125 trend, for the reasons set out above.

The impression is the reporting physician’s summary and the part your gynae-oncologist reads first.

Radiation and safety

A PET CT involves ionising radiation from the tracer and the CT component, which is why it is ordered for specific clinical questions rather than routinely. Fluorine-18 has a half-life of under two hours, and essentially none remains active by the following day.

Precautions afterwards are simple and temporary: drink water, empty your bladder frequently for the first few hours, and keep some distance from pregnant women and young children for the rest of the day.

If there is any possibility of pregnancy, this must be discussed before anything is injected.

What decides the cost

Ovarian studies are usually FDG whole body, which is Rs 7,999 all-inclusive — the figure includes the scan, the tracer and the reporting, and nothing is added at the counter. Contrast or delayed pelvic images are occasionally required by the protocol; send the prescription and we will confirm the complete figure for your exact study in writing.

Ask these before you book

  1. Is the tracer included in the figure you quoted?
  2. Is contrast included, if my protocol requires it?
  3. Are delayed pelvic images included if needed?
  4. Is reporting included?
  5. What is the total I will pay at the counter? In writing.
  6. Will my previous CT scans and operative notes be taken into account?
  7. Is this the right interval after my last chemotherapy cycle?
  8. Can positioning be adapted if I have ascites and cannot lie flat easily?

Where Neurad fits

Neurad Diagnostic and Healthcare LLP is a dedicated PET-CT and nuclear medicine centre at B-3, opposite Metro Pillar No. 233, near Paschim Vihar West Metro Station, New Multan Nagar, Paschim Vihar, New Delhi-110056. Monday to Saturday, 8:00 AM to 5:00 PM.

Reported by our own nuclear medicine team, not outsourced.

Your previous scans, operative notes and CA-125 trend taken into account, provided you bring them.

Written preparation instructions specific to your study, including the hydration and voiding guidance that matters in pelvic imaging.

Positioning planned in advance if ascites or abdominal distension makes lying flat difficult. Tell us at booking.

Blood sugar checked before injection as standard, with diabetic patients planned in advance.

Female staff present on request — ask at the time of booking and it will be arranged.

Image-guided FNAC and biopsy available, so where a lesion needs tissue confirmation it can often be arranged without another centre and another journey.

Complimentary pickup and drop within 3 km; beyond that, Rs 50 per km.

The all-inclusive figure in writing before you book.

Frequently asked questions

Do I need a PET scan when ovarian cancer is first diagnosed?

Usually not. Initial assessment is generally ultrasound, contrast CT, CA-125 and clinical evaluation, with staging determined surgically. PET is used mainly for suspected recurrence, rising CA-125 with unclear imaging, and assessing whether recurrent disease is operable.

Why is staging surgical rather than by scan?

Because ovarian cancer spreads by seeding across the peritoneum, often as numerous very small deposits that no scan reliably detects. A surgeon can see and feel those surfaces directly.

My CA-125 is rising but the CT is normal. What now?

This is the commonest reason for a PET in ovarian cancer. PET can identify metabolically active disease before it produces a structural change visible on CT. If the PET is also clear, your team may repeat imaging after an interval rather than concluding either way.

Can CA-125 rise without cancer returning?

Yes. Endometriosis, fibroids, pelvic inflammation, liver disease, heart failure, recent surgery and even menstruation can raise it. A single value is a reason to investigate, not a diagnosis — the trend across readings is more informative.

Does a clear PET mean the cancer has not come back?

Not with certainty. Small peritoneal deposits fall below reliable detection on any scan. A clear PET is reassuring but is read alongside your CA-125 trend, symptoms and examination — which is why your doctor may not treat a normal scan as the final word.

Why might my doctor suggest laparoscopy after a scan?

Because where the exact extent of peritoneal disease matters — for instance in deciding whether cytoreductive surgery is feasible — direct visualisation sees what imaging cannot. It complements the scan rather than duplicating it.

Why do they ask about my menstrual cycle?

Because in premenopausal women the ovaries and endometrium show cyclical FDG uptake. Knowing where you are in your cycle helps distinguish a normal pattern from a significant finding.

Why am I asked to drink water and empty my bladder?

The tracer is excreted in urine and collects in the bladder, which sits directly in front of the pelvic organs being assessed. Hydration dilutes it and voiding clears it. These instructions affect whether the pelvis can be read properly.

I have ascites and cannot lie flat comfortably. Can I still have the scan?

Yes, but tell the centre at booking. Positioning can be adapted, and discomfort causes movement which degrades the images.

Should I bring my operative notes?

Yes. In a disease where surgery is the definitive staging assessment, knowing what was found and what was removed materially changes how later imaging is interpreted.

Can I ask for a female staff member?

Yes, and asking at the time of booking makes it straightforward to arrange.

What does an ovarian cancer PET CT cost?

Ovarian cancer studies are usually FDG whole body, which is Rs 7,999 all-inclusive of scan, tracer and reporting. Contrast or delayed pelvic images can change the figure. Send the prescription on WhatsApp and we will share the all-inclusive figure for your exact study before you book.

Do I need a prescription?

Yes. A valid prescription is required for all PET CT studies, and it should state the clinical indication.

Related reading

Booking your scan

Send a photograph of the prescription to 8368225620 on WhatsApp. Include four things: your CA-125 results over time if the scan was prompted by a rise, the date of your surgery, whether you have ascites or difficulty lying flat, and the date of your last chemotherapy cycle.

You will get the all-inclusive rate, a slot planned around the right interval, preparation instructions including the hydration and voiding guidance, and a note on which reports to carry — operative notes in particular.

Prefer to speak to someone? Call 8368225620 or 7011968879, Monday to Saturday, 8:00 AM to 5:00 PM. Ask for a female staff member to be present if you would prefer that.

This page is general information about the role of PET CT in ovarian cancer. It is not medical advice and must not be used to interpret your own report or CA-125 results, or to decide for or against a scan or an operation. Staging and treatment decisions are made by your treating team, who read the scan alongside surgery, pathology, tumour markers and examination. A valid prescription is required for all PET CT studies.

Ready to book?Mon–Sat, 8 AM – 5 PM · Paschim Vihar

Book a scan Call
Book a scan Call now
Scroll to Top